Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 24% ± 9% | |
classical monocyte | 4 studies | 25% ± 7% | |
macrophage | 4 studies | 22% ± 5% | |
ionocyte | 3 studies | 29% ± 8% | |
endothelial cell | 3 studies | 17% ± 2% | |
myeloid cell | 3 studies | 19% ± 3% | |
astrocyte | 3 studies | 27% ± 1% |
Insufficient scRNA-seq data for expression of INPPL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 14965.48 | 245 / 245 | 100% | 75.16 | 502 / 502 |
skin | 100% | 6696.96 | 1808 / 1809 | 100% | 90.84 | 472 / 472 |
ovary | 100% | 13473.36 | 180 / 180 | 100% | 115.76 | 429 / 430 |
breast | 100% | 9404.24 | 459 / 459 | 100% | 69.35 | 1115 / 1118 |
uterus | 100% | 13161.91 | 170 / 170 | 100% | 61.92 | 457 / 459 |
thymus | 100% | 15460.90 | 653 / 653 | 100% | 54.99 | 602 / 605 |
esophagus | 100% | 11356.58 | 1445 / 1445 | 99% | 73.49 | 182 / 183 |
pancreas | 100% | 5572.15 | 328 / 328 | 99% | 57.65 | 177 / 178 |
intestine | 100% | 14197.04 | 966 / 966 | 99% | 56.59 | 524 / 527 |
kidney | 100% | 10393.10 | 89 / 89 | 99% | 57.39 | 895 / 901 |
stomach | 100% | 9406.47 | 359 / 359 | 99% | 59.12 | 284 / 286 |
bladder | 100% | 11716.14 | 21 / 21 | 99% | 56.74 | 500 / 504 |
lung | 100% | 12693.66 | 578 / 578 | 99% | 65.62 | 1145 / 1155 |
adrenal gland | 100% | 10692.35 | 258 / 258 | 98% | 45.35 | 226 / 230 |
brain | 90% | 3796.48 | 2381 / 2642 | 100% | 81.60 | 704 / 705 |
liver | 99% | 3742.32 | 223 / 226 | 88% | 29.89 | 359 / 406 |
adipose | 100% | 8667.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 80.09 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 64.61 | 29 / 29 |
muscle | 100% | 10583.17 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 12860.41 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 36.77 | 1 / 1 |
blood vessel | 100% | 10089.36 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 8107.57 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 8300.28 | 915 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 31.42 | 42 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002376 | Biological process | immune system process |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006897 | Biological process | endocytosis |
GO_0009791 | Biological process | post-embryonic development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0032868 | Biological process | response to insulin |
GO_0046856 | Biological process | phosphatidylinositol dephosphorylation |
GO_0007155 | Biological process | cell adhesion |
GO_0097178 | Biological process | ruffle assembly |
GO_0001958 | Biological process | endochondral ossification |
GO_0050776 | Biological process | regulation of immune response |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0007015 | Biological process | actin filament organization |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0043569 | Biological process | negative regulation of insulin-like growth factor receptor signaling pathway |
GO_0006915 | Biological process | apoptotic process |
GO_0010467 | Biological process | gene expression |
GO_0006006 | Biological process | glucose metabolic process |
GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
GO_0000922 | Cellular component | spindle pole |
GO_0016607 | Cellular component | nuclear speck |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0030175 | Cellular component | filopodium |
GO_0005829 | Cellular component | cytosol |
GO_0030027 | Cellular component | lamellipodium |
GO_0005634 | Cellular component | nucleus |
GO_0034485 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity |
GO_0003779 | Molecular function | actin binding |
GO_0042169 | Molecular function | SH2 domain binding |
GO_0004445 | Molecular function | inositol-polyphosphate 5-phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | INPPL1 |
Protein name | Inositol polyphosphate phosphatase like 1 Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2) |
Synonyms | SHIP2 |
Description | FUNCTION: Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways . Required for correct mitotic spindle orientation and therefore progression of mitosis (By similarity). Plays a central role in regulation of PI3K-dependent insulin signaling, although the precise molecular mechanisms and signaling pathways remain unclear . While overexpression reduces both insulin-stimulated MAP kinase and Akt activation, its absence does not affect insulin signaling or GLUT4 trafficking (By similarity). Confers resistance to dietary obesity (By similarity). May act by regulating AKT2, but not AKT1, phosphorylation at the plasma membrane (By similarity). Part of a signaling pathway that regulates actin cytoskeleton remodeling . Required for the maintenance and dynamic remodeling of actin structures as well as in endocytosis, having a major impact on ligand-induced EGFR internalization and degradation . Participates in regulation of cortical and submembraneous actin by hydrolyzing PtdIns(3,4,5)P3 thereby regulating membrane ruffling . Regulates cell adhesion and cell spreading . Required for HGF-mediated lamellipodium formation, cell scattering and spreading . Acts as a negative regulator of EPHA2 receptor endocytosis by inhibiting via PI3K-dependent Rac1 activation . Acts as a regulator of neuritogenesis by regulating PtdIns(3,4,5)P3 level and is required to form an initial protrusive pattern, and later, maintain proper neurite outgrowth (By similarity). Acts as a negative regulator of the FC-gamma-RIIA receptor (FCGR2A) . Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems . Involved in EGF signaling pathway . Upon stimulation by EGF, it is recruited by EGFR and dephosphorylates PtdIns(3,4,5)P3 . Plays a negative role in regulating the PI3K-PKB pathway, possibly by inhibiting PKB activity . Down-regulates Fc-gamma-R-mediated phagocytosis in macrophages independently of INPP5D/SHIP1 (By similarity). In macrophages, down-regulates NF-kappa-B-dependent gene transcription by regulating macrophage colony-stimulating factor (M-CSF)-induced signaling (By similarity). Plays a role in the localization of AURKA and NEDD9/HEF1 to the basolateral membrane at interphase in polarized cysts, thereby mediates cell cycle homeostasis, cell polarization and cilia assembly (By similarity). Additionally promotion of cilia growth is also facilitated by hydrolysis of (PtdIns(3,4,5)P3) to PtdIns(3,4)P2 (By similarity). Promotes formation of apical membrane-initiation sites during the initial stages of lumen formation via Rho family-induced actin filament organization and CTNNB1 localization to cell-cell contacts (By similarity). May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6. Involved in endochondral ossification . . |
Accessions | ENST00000540329.5 F5GY16 H7BXR2 F5GWY9 ENST00000538751.5 [O15357-2] F5GYK9 ENST00000320683.7 O15357 H0YFB4 ENST00000537656.1 H0YFZ4 ENST00000535985.1 ENST00000543234.1 ENST00000541752.1 F5H588 ENST00000298229.7 [O15357-1] ENST00000540973.1 |